(Q48584188)

English

Phase I and II trials of novel anti-cancer agents: endpoints, efficacy and existentialism. The Michel Clavel Lecture, held at the 10th NCI-EORTC Conference on New Drugs in Cancer Therapy, Amsterdam, 16-19 June 1998.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9834816

Phase I and II trials of novel anti-cancer agents: endpoints, efficacy and existentialism. The Michel Clavel Lecture, held at the 10th NCI-EORTC Conference on New Drugs in Cancer Therapy, Amsterdam, 16-19 June 1998. (English)

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9834816

phase I clinical trial

0 references

1 reference

based on heuristic

inferred from title

author name string

E A Eisenhauer

1

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9834816

publication date

1 October 1998

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9834816

Annals of Oncology

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9834816

9

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9834816

10

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9834816

1047-1052

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9834816

Suramin-induced decrease in prostate-specific antigen expression with no effect on tumor growth in the LNCaP model of human prostate cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008497110734

7 January 2021

based on heuristic

inferred from DOI database lookup

PET scanning in clinical oncology

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008497110734

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008497110734

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug delivery analysis of the Canadian multicenter trial in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008497110734

7 January 2021

based on heuristic

inferred from DOI database lookup

One-sample multiple testing procedure for phase II clinical trials

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008497110734

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008497110734

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9834816

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/9834816

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48584188&oldid=1749506621"